EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Repeated and multiple fecal microbiota transplantations plus partial enteral nutrition as the first-line treatment in active pediatric Crohn’s disease

Biao Zou, Shengxuan Liu, Xuesong Li, Jiayi He, Chen Dong, Mengling Ruan, Zhihua Huang, Sainan Shu

Frontiers in Cellular and Infection Microbiology · 2023

DOI: 10.3389/fcimb.2023.1083236 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2023. Verfasst von Biao Zou und 7 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Department, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China. Hauptthemen laut MEDLINE: Crohn Disease. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Most studies have reported fecal microbiota transplantation (FMT) as an effective secondary option for Crohn’s disease (CD). However, there is little data on FMT as a first-line treatment for CD. In our study we explore the rates of clinical and endoscopic remission and mucosal healing after FMT plus partial enteral nutrition (PEN), as a first-line treatment for active CD in children.

Methods

We retrospectively enrolled pediatric CD patients who underwent PEN or PEN plus FMT treatment at diagnosis from November 2016 to July 2019 at the Pediatric Department, Tongji Hospital. The two groups were defined as FMT group (repeated and multiple doses of FMT plus PEN) or PEN group (PEN alone). All the patients received PEN intervention. At baseline and week 8- 10, the FMT group was administered multiple doses of FMT to help induce and maintain remission. All patients were evaluated at week 8- 10 and 18-22 via clinical and relevant laboratory parameters and endoscopic results. The clinical and endoscopic remission and mucosal healing rates were compared between the two groups at different time points after the therapy.

Results

Twenty-five newly diagnosed active CD patients were included in the study, containing 7 females and 18 males with a median age of 11. 1 ± 2.3 years. 13 and 12 patients were assigned to the PEN and FMT groups, respectively. At week 8-10, clinical remission was obtained in 83.3% and 53.8% of the FMT and PEN groups, respectively (p=0.202). The endoscopic remission rates were 72.7% for FMT and 25.0% for PEN (p=0.039), whereas the mucosal healing rates were 27.2% for FMT and 0% for PEN (p=0.093). At week 18-22, clinical remission was achieved in 72.7% and 20.0% of patients in the FMT and PEN groups, respectively (p=0.03). Theendoscopic remission rates were 66.6% and 12.5% in the FMT and PEN groups, respectively (p=0.05), whereas the mucosal healing rates were 55.5% and 0% in FMT and PEN groups, respectively (p=0.029).

Conclusion

This study demonstrate that FMT plus PEN can be used as a first-line treatment for active CD in children.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Crohn DiseaseMaleChildFemaleHumansFecal Microbiota TransplantationEnteral NutritionRetrospective StudiesRemission InductionPenicillin GTreatment Outcome

Stichwörter der Autor:innen

Crohn’s diseasefecal microbiota transplantationfirst-line treatmentpartial enteral nutritionpediatric

Substanzen

Penicillin G

Autor:innen und Institutionen

  • Pediatric Department, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.

Zitieren

APA

Zou, B., Liu, S., Li, X., He, J., Dong, C., Ruan, M., Huang, Z., & Shu, S. (2023). Repeated and multiple fecal microbiota transplantations plus partial enteral nutrition as the first-line treatment in active pediatric Crohn’s disease. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2023.1083236

Vancouver

Zou B, Liu S, Li X, He J, Dong C, Ruan M, et al. Repeated and multiple fecal microbiota transplantations plus partial enteral nutrition as the first-line treatment in active pediatric Crohn’s disease. Frontiers in Cellular and Infection Microbiology. 2023. doi:10.3389/fcimb.2023.1083236

BibTeX
@article{Zou2023,
  author = {Zou, Biao and Liu, Shengxuan and Li, Xuesong and He, Jiayi and Dong, Chen and Ruan, Mengling and Huang, Zhihua and Shu, Sainan},
  title = {Repeated and multiple fecal microbiota transplantations plus partial enteral nutrition as the first-line treatment in active pediatric Crohn’s disease},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2023},
  doi = {10.3389/fcimb.2023.1083236}
}
Kostenlos starten →